HighTower Advisors’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6K | Sell |
10,148
-963
| -9% | -$1.19K | ﹤0.01% | 3568 |
|
|
2025
Q1 | $13.1K | Sell |
11,111
-2,692
| -20% | -$3.18K | ﹤0.01% | 3470 |
|
|
2024
Q4 | $25.3K | Sell |
13,803
-2,795
| -17% | -$5.12K | ﹤0.01% | 3439 |
|
|
2024
Q3 | $26K | Sell |
16,598
-8,318
| -33% | -$13K | ﹤0.01% | 3415 |
|
|
2024
Q2 | $32K | Sell |
24,916
-19,505
| -44% | -$25.1K | ﹤0.01% | 3299 |
|
|
2024
Q1 | $165K | Sell |
44,421
-2,136
| -5% | -$7.93K | ﹤0.01% | 3013 |
|
|
2023
Q4 | $458K | Sell |
46,557
-25,540
| -35% | -$251K | ﹤0.01% | 2371 |
|
|
2023
Q3 | $601K | Sell |
72,097
-6,244
| -8% | -$52.1K | ﹤0.01% | 2096 |
|
|
2023
Q2 | $1.04M | Sell |
78,341
-11,565
| -13% | -$154K | ﹤0.01% | 1727 |
|
|
2023
Q1 | $1.04M | Buy |
89,906
+3,183
| +4% | +$36.9K | ﹤0.01% | 1642 |
|
|
2022
Q4 | $708K | Sell |
86,723
-21,415
| -20% | -$175K | ﹤0.01% | 1868 |
|
|
2022
Q3 | $630K | Sell |
108,138
-52,285
| -33% | -$305K | ﹤0.01% | 1867 |
|
|
2022
Q2 | $703K | Sell |
160,423
-48,232
| -23% | -$211K | ﹤0.01% | 1842 |
|
|
2022
Q1 | $1.9M | Buy |
208,655
+117,770
| +130% | +$1.07M | ﹤0.01% | 1404 |
|
|
2021
Q4 | $1.86M | Buy |
90,885
+9,646
| +12% | +$198K | ﹤0.01% | 1394 |
|
|
2021
Q3 | $2.08M | Sell |
81,239
-1,321
| -2% | -$33.8K | 0.01% | 1235 |
|
|
2021
Q2 | $2.89M | Sell |
82,560
-10,253
| -11% | -$358K | 0.01% | 1036 |
|
|
2021
Q1 | $3.09M | Buy |
92,813
+78,513
| +549% | +$2.61M | 0.01% | 916 |
|
|
2020
Q4 | $371K | Buy |
+14,300
| New | +$371K | ﹤0.01% | 1775 |
|
|
2017
Q3 | – | Sell |
-27,785
| Closed | -$101K | – | 2175 |
|
|
2017
Q2 | $101K | Buy |
27,785
+7,225
| +35% | +$26.3K | ﹤0.01% | 1950 |
|
|
2017
Q1 | $94K | Buy |
+20,560
| New | +$94K | ﹤0.01% | 1869 |
|